Marc was the president and CEO of Genome Canada from 2016 to 2021. He led an ambitious national research program to develop applications in human health, agriculture/food, forestry, environment/climate change, natural resources, and fisheries. He developed several important partnerships including a national effort to implement a country-wide clinical genomics for rare disease patients.

He was President and CEO of Genome Quebec from 2012 to 2016 where he worked closely with the provincial government to align research with public policy priorities.

He spent many years abroad as a member of Canada’s foreign service. From 2005 to 2012 he served as Special Advisor for Climate Change and Energy at the Canadian Embassy in Washington, D.C. and as Consul General at the Canadian Consulate in San Francisco/Silicon Valley. Earlier in his career, he carried out various trade promotion assignments in Cuba, Sweden, France, and California (San Diego).

He worked as Director of Business Development for the Medical Research Council, where he was responsible for developing partnerships with the pharmaceutical industry, venture capital and foundations. He was a member of MRC’s leadership team that led to the creation of the Canadian Institutes of Health Research.

Over the years, he has served on a number of other boards including Oxfam Canada, the MRC/PMAC Health Program and the Ottawa Hospital Foundation board committees on risk and on commercialization. He is also a senior advisor to Global Advantage, an Ottawa-based firm specializing in innovation and research policy.